FDA Inspection 1278362 — BIPSO GmbH
The FDA completed an inspection of BIPSO GmbH on May 4, 2022 in Singen (Hohentwiel). The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- May 4, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Singen (Hohentwiel) (Germany)
Additional Details
Mutual Recognition Agreement (MRA)